Literature DB >> 34183531

Identifiability and Estimation Under the Test-negative Design With Population Controls With the Goal of Identifying Risk and Preventive Factors for SARS-CoV-2 Infection.

Mireille E Schnitzer1, Daphna Harel, Vikki Ho, Anita Koushik, Joanna Merckx.   

Abstract

Owing to the rapidly evolving coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, quick public health investigations of the relationships between behaviors and infection risk are essential. Recently the test-negative design (TND) was proposed to recruit and survey participants who are symptomatic and being tested for SARS-CoV-2 infection with the goal of evaluating associations between the survey responses (including behaviors and environment) and testing positive on the test. It was also proposed to recruit additional controls who are part of the general population as a baseline comparison group to evaluate risk factors specific to SARS-CoV-2 infection. In this study, we consider an alternative design where we recruit among all individuals, symptomatic and asymptomatic, being tested for the virus in addition to population controls. We define a regression parameter related to a prospective risk factor analysis and investigate its identifiability under the two study designs. We review the difference between the prospective risk factor parameter and the parameter targeted in the typical TND where only symptomatic and tested people are recruited. Using missing data directed acyclic graphs, we provide conditions and required data collection under which identifiability of the prospective risk factor parameter is possible and compare the benefits and limitations of the alternative study designs and target parameters. We propose a novel inverse probability weighting estimator and demonstrate the performance of this estimator through simulation study.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34183531     DOI: 10.1097/EDE.0000000000001385

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  3 in total

1.  Estimands and Estimation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Connections to Causal Inference.

Authors:  Mireille E Schnitzer
Journal:  Epidemiology       Date:  2022-05-01       Impact factor: 4.822

2.  Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.

Authors:  Sara Carazo; Danuta M Skowronski; Marc Brisson; Sapha Barkati; Chantal Sauvageau; Nicholas Brousseau; Rodica Gilca; Judith Fafard; Denis Talbot; Manale Ouakki; Vladimir Gilca; Alex Carignan; Geneviève Deceuninck; Philippe De Wals; Gaston De Serres
Journal:  Lancet Infect Dis       Date:  2022-09-21       Impact factor: 71.421

3.  Risk and protective factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers: A test-negative case-control study in Québec, Canada.

Authors:  Sara Carazo; Jasmin Villeneuve; Denis Laliberté; Yves Longtin; Denis Talbot; Richard Martin; Geoffroy Denis; Francine Ducharme; Bianka Paquet-Bolduc; Geneviève Anctil; Sandrine Hegg-Deloye; Gaston De Serres
Journal:  Infect Control Hosp Epidemiol       Date:  2022-09-09       Impact factor: 6.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.